WO2000023059A2 - Use of anticonvulsant derivatives for treating alcohol dependency - Google Patents
Use of anticonvulsant derivatives for treating alcohol dependency Download PDFInfo
- Publication number
- WO2000023059A2 WO2000023059A2 PCT/US1999/023769 US9923769W WO0023059A2 WO 2000023059 A2 WO2000023059 A2 WO 2000023059A2 US 9923769 W US9923769 W US 9923769W WO 0023059 A2 WO0023059 A2 WO 0023059A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- alkyl
- hydrogen
- treating
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000576834A JP2002527470A (en) | 1998-10-20 | 1999-10-18 | Anticonvulsant derivatives useful in the treatment of alcoholism, addiction and abuse |
BR9914722-0A BR9914722A (en) | 1998-10-20 | 1999-10-18 | Anticonvulsant derivatives useful in the treatment of alcohol dependence, addiction and abuse |
AU13131/00A AU759756B2 (en) | 1998-10-20 | 1999-10-18 | Anticonvulsant derivatives useful in treating alcohol dependency, addiction and abuse |
NZ511173A NZ511173A (en) | 1998-10-20 | 1999-10-18 | Method for treating alcohol dependency, addiction and abuse using anticonvulsant derivatives (such as 2,3:4,5-bis- O-(1-methylethylidene)-beta-D-fructopyranose sulfamate (topiramate)) |
CA002348017A CA2348017C (en) | 1998-10-20 | 1999-10-18 | Anticonvulsant derivatives useful in treating alcohol dependency, addiction and abuse |
MXPA01004015A MXPA01004015A (en) | 1998-10-20 | 1999-10-18 | Anticonvulsant derivatives useful in treating alcohol dependency, addiction and abuse. |
NO20011901A NO20011901L (en) | 1998-10-20 | 2001-04-18 | Anti-convulsive derivatives useful in the treatment of alcohol dependence and abuse |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10488798P | 1998-10-20 | 1998-10-20 | |
US60/104,887 | 1998-10-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000023059A2 true WO2000023059A2 (en) | 2000-04-27 |
WO2000023059A3 WO2000023059A3 (en) | 2000-11-23 |
Family
ID=22302937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/023769 WO2000023059A2 (en) | 1998-10-20 | 1999-10-18 | Use of anticonvulsant derivatives for treating alcohol dependency |
Country Status (9)
Country | Link |
---|---|
JP (1) | JP2002527470A (en) |
AU (1) | AU759756B2 (en) |
BR (1) | BR9914722A (en) |
CA (1) | CA2348017C (en) |
MX (1) | MXPA01004015A (en) |
NO (1) | NO20011901L (en) |
NZ (1) | NZ511173A (en) |
WO (1) | WO2000023059A2 (en) |
ZA (1) | ZA200104037B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000050020A2 (en) * | 1999-02-24 | 2000-08-31 | University Of Cincinnati | Use of sulfamate derivatives for treating impulse control disorders |
US6323239B1 (en) | 1998-08-05 | 2001-11-27 | Brookhaven Science Associates | Treatment of addiction to ethanol and addictive-related behavior |
WO2002043731A3 (en) * | 2000-11-30 | 2003-02-20 | Univ Florida | Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
EP1392273A1 (en) * | 2001-05-14 | 2004-03-03 | Brookhaven Science Associates | Novel treatment for obsessive-compulsive disorder (ocd) and ocd-related disorders using gvg |
US6890951B2 (en) | 1998-08-05 | 2005-05-10 | Brookhaven Science Associates Llc | Treatment of addiction and addiction-related behavior |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000007583A2 (en) * | 1998-08-05 | 2000-02-17 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
-
1999
- 1999-10-18 NZ NZ511173A patent/NZ511173A/en unknown
- 1999-10-18 CA CA002348017A patent/CA2348017C/en not_active Expired - Fee Related
- 1999-10-18 JP JP2000576834A patent/JP2002527470A/en active Pending
- 1999-10-18 BR BR9914722-0A patent/BR9914722A/en not_active Application Discontinuation
- 1999-10-18 MX MXPA01004015A patent/MXPA01004015A/en not_active Application Discontinuation
- 1999-10-18 WO PCT/US1999/023769 patent/WO2000023059A2/en active IP Right Grant
- 1999-10-18 AU AU13131/00A patent/AU759756B2/en not_active Ceased
-
2001
- 2001-04-18 NO NO20011901A patent/NO20011901L/en not_active Application Discontinuation
- 2001-05-17 ZA ZA200104037A patent/ZA200104037B/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000007583A2 (en) * | 1998-08-05 | 2000-02-17 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
Non-Patent Citations (4)
Title |
---|
D.A. GORELICK: "Pharmacological treatment" RECENT DEVELOPMENTS IN ALCOHOLISM, vol. 11, 1993, pages 413-427, XP000913482 * |
KYOWA HAKKO: "TOPIRAMATE" DRUGS OF THE FUTURE,ES,BARCELONA, vol. 21, no. 4, 1 January 1996 (1996-01-01), pages 463-465, XP002043895 ISSN: 0377-8282 * |
T.I. MIELLER: "A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence" ALCOHOLISM. CLIN. EXP. RES., vol. 21, no. 1, 1997, pages 86-92, XP000913485 * |
WAUQUIER A ET AL: "TOPIRAMATE: A POTENT ANTICONVULSANT IN THE AMYGDALA-KINDLED RAT" EPILEPSY RESEARCH,NL,ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, vol. 24, no. 2, 1 June 1996 (1996-06-01), pages 73-77, XP002042953 ISSN: 0920-1211 * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6890951B2 (en) | 1998-08-05 | 2005-05-10 | Brookhaven Science Associates Llc | Treatment of addiction and addiction-related behavior |
US6323239B1 (en) | 1998-08-05 | 2001-11-27 | Brookhaven Science Associates | Treatment of addiction to ethanol and addictive-related behavior |
US6906099B2 (en) | 1998-08-05 | 2005-06-14 | Brookhaven Science Associates, Llc | Treatment of addiction and addiction-related behavior using a composition of topiramate |
WO2000050020A3 (en) * | 1999-02-24 | 2000-12-21 | Univ Cincinnati | Use of sulfamate derivatives for treating impulse control disorders |
US6323236B2 (en) | 1999-02-24 | 2001-11-27 | University Of Cincinnati | Use of sulfamate derivatives for treating impulse control disorders |
WO2000050020A2 (en) * | 1999-02-24 | 2000-08-31 | University Of Cincinnati | Use of sulfamate derivatives for treating impulse control disorders |
WO2002043731A3 (en) * | 2000-11-30 | 2003-02-20 | Univ Florida | Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
US8084491B2 (en) | 2000-11-30 | 2011-12-27 | Novodermix International Limited | Treatments for wound healing |
EP1392273A4 (en) * | 2001-05-14 | 2004-11-24 | Brookhaven Science Ass Llc | Novel treatment for obsessive-compulsive disorder (ocd) and ocd-related disorders using gvg |
EP1392273A1 (en) * | 2001-05-14 | 2004-03-03 | Brookhaven Science Associates | Novel treatment for obsessive-compulsive disorder (ocd) and ocd-related disorders using gvg |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US8889190B2 (en) | 2013-03-13 | 2014-11-18 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
US10363224B2 (en) | 2013-03-13 | 2019-07-30 | Upsher-Smith Laboratories, Llc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
US9555005B2 (en) | 2013-03-15 | 2017-01-31 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
US10172878B2 (en) | 2013-03-15 | 2019-01-08 | Upsher-Smith Laboratories, Llc | Extended-release topiramate capsules |
Also Published As
Publication number | Publication date |
---|---|
AU1313100A (en) | 2000-05-08 |
NO20011901D0 (en) | 2001-04-18 |
WO2000023059A3 (en) | 2000-11-23 |
NZ511173A (en) | 2003-09-26 |
ZA200104037B (en) | 2002-06-28 |
CA2348017A1 (en) | 2000-04-27 |
CA2348017C (en) | 2005-07-19 |
NO20011901L (en) | 2001-04-18 |
BR9914722A (en) | 2001-07-10 |
MXPA01004015A (en) | 2003-03-10 |
AU759756B2 (en) | 2003-05-01 |
JP2002527470A (en) | 2002-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2258893C (en) | Anticonvulsant sulfamate derivatives useful in treating obesity | |
CA2369099C (en) | Anticonvulsant derivatives useful in reducing blood glucose levels | |
CA2258895C (en) | Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders | |
CA2369091C (en) | Anticonvulsant derivatives useful in lowering blood pressure | |
AU774732B2 (en) | Anticonvulsant derivatives useful in lowering lipids | |
US20020052325A1 (en) | Anticonvulsant derivatives useful in maintaining weight loss | |
CA2267945C (en) | Anticonvulsant derivatives useful in treating neuropathic pain | |
AU759756B2 (en) | Anticonvulsant derivatives useful in treating alcohol dependency, addiction and abuse | |
US6472370B1 (en) | Anticonvulsant derivatives useful in treating post traumatic stress disorder | |
WO2000066108A2 (en) | Anticonvulsant derivatives useful in treating cocaine dependency |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2000 13131 Country of ref document: AU Kind code of ref document: A |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2000 576834 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 511173 Country of ref document: NZ Ref document number: 13131/00 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2348017 Country of ref document: CA Kind code of ref document: A Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/004015 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001/04037 Country of ref document: ZA Ref document number: 200104037 Country of ref document: ZA |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
WWG | Wipo information: grant in national office |
Ref document number: 13131/00 Country of ref document: AU |